DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Mittendorf EA, Zhang H, Barrios CH. et al.
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and
anthracycline-based chemotherapy versus placebo and chemotherapy in patients
with early-stage triple-negative breast cancer (IMpassion031): a randomised,
double-blind, phase 3 trial.
Lancet 2020;
396: 1090-1100
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.